Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Vir Biotechnology is a leading US-based biotechnology company dedicated to developing innovative therapies and prevention strategies for serious infectious diseases. The company leverages advanced immunology and technologies, such as monoclonal antibodies, to protect patients globally and improve lives.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Vir Biotechnology is scheduled to report its next quarterly earnings on 10/29/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Vir Biotechnology last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 0.47 USD.
Across its last 3 earnings reports, Vir Biotechnology stock moved by ±14.3% on average the following day. The largest reaction was +27.7% on 02/23/2026; 1 of 3 reactions were positive.
Vir Biotechnology has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.